Clozapine-induced agranulocytosis: A case report immunopathophysiological considerations

Netherlands Journal of Medicine

Volumn 52, Issue 1, 1998, Pages 26-29

  Van De Loosdrecht, A A ^a   Faber, H J ^a   Hordijk, P ^b   Uges, D R A ^a   Smit, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Psychiatric Hospital Dennenoord   (Netherlands)

Author keywords

Agranulocytosis; Clozapine; Granulocyte colony stimulating factor

Indexed keywords

ANTIBIOTIC AGENT; CLOZAPINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR;

ADULT; AGRANULOCYTOSIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; FEMALE; HUMAN; INFECTION; INFECTION PREVENTION; INFECTIOUS COMPLICATION; PSYCHOSIS;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CILASTATIN; CLOZAPINE; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMIPENEM; LEUKOCYTE COUNT; MIDDLE AGED; NETHERLANDS; SCHIZOPHRENIA;

EID: 0031893755     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00074-0     Document Type: Article

References (16)

1. Gerson S.L. G-CSF and the management of clozapine-induced agranulocytosis. J. Clin. Psychiatry. 55(suppl. B):1994;139-142.
2. Sprikkelman A., De Wolf J.T.M., Vellenga E. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia. 8:1994;2031-2036.
3. Baldessarini R.J., Frankenburg F.R. Clozapine a novel antipsychotic agent. New Engl. J. Med. 324:1991;746-754.
4. Kerwin R.W. Clozapine: back to the future for schizophrenia research. Lancet. 345:1995;1063-1064.
5. Montero D., Santamaria B., Rayon P., De Abajo F.J. Time for less control of clozapine? Lancet. 346:1995;56.
6. Alvir J.M.J., Lieberman J.A. Agranulocytosis: Incidence and risk factors. J. Clin. Psychiatry. 55(suppl. B):1994;137-138.
7. Alvir J.M.J., Lieberman J.A., Safferman A.Z., Schwimmer J.L., Schaaf J.A. Clozapine-induced agranulocytosis. Incidence and risk factors in the united states. New Engl. J. Med. 329:1993;162-167.
8. Vincent P.C. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms. Drugs. 31:1986;52-63.
9. Gerson S.L., Arce C., Meltzer H.Y. N-Desmethylclozapine metabolite that suppresses haemopoiesis. Br. J. Haematol. 86:1994;555-561.
10. Pfister G.M., Hanson D.R., Roerig J.L., Landboom R., Popkin M.K. Clozapine-induced agranulocytosis in a native American: HLA typing and further support for an immune-mediated mechanism. J. Clin. Psychiatry. 53:1992;242-244.
11. Pisciotta A.Y., Konings S.A. 51 Cr release assay of clozapine-induced cytotoxicity: evidence for immunogenic mechanism. J. Clin. Psychiatry. 55:1994;143-148.
12. Lieberman J.A., Johns C.A., Kane J.M.et al. Clozapine-induced agranulocytosis. Non-cross-reactivity with other psychotropic drugs. J. Clin. Psychiatry. 49:1988;271-277.
13. Corzo D.C., Yunis J.J., Yunis E.J., Howard A., Lieberman J.A. HSP70-2 9.0 kb variant is in linkage disequilibrium with HLA-B and DRB1 alleles associated with clozapine-induced agranulocytosis. J. Clin. Psychiatry. 55:1994;149-152.
14. Barnas C., Zwierzina H., Hummer M., Sperner-Unterweger B., Stern A., Fleischhacker W.W. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report. J. Clin. Psychiatry. 53:1992;245-247.
15. Gerson S.L., Gullion G., Yeh H.S., Masor C. Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis. Lancet. 340:1992;1097.
16. Weide R., Köppler H., Heymanns J., Pflüger K.H., Havemann K. Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). Br. J. Haematol. 80:1992;557-559.